Alumis (ALMS) Cash from Investing Activities (2023 - 2025)

Alumis' (ALMS) quarterly Cash from Investing Activities came in at $95.0 million in Q4 2025, up 206.99% year-on-year from $31.0 million in Q4 2024, and up 295.29% on a QoQ basis from $24.0 million in Q3 2025.

Alumis (ALMS) Cash from Investing Activities (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Cash from Investing Activities data on file, last reported at $95.0 million in Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 206.99% year-over-year to $95.0 million in Q4 2025; TTM through Dec 2025 was $287.9 million, a 352.99% increase from a year earlier, with the FY2025 full-year figure at $287.9 million, up 352.99% from the prior year.
  • Cash from Investing Activities for Q4 2025 stood at $95.0 million, up from $24.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for ALMS reached as high as $129.4 million in Q2 2025 and fell as low as -$93.2 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged $17.8 million across 3 years, with a median of $15.8 million in 2023.
  • On a YoY basis, Cash from Investing Activities climbed as much as 846.86% in 2024 and fell as far as 1330.06% in 2024.
  • Year by year, Cash from Investing Activities stood at -$4.1 million in 2023, then jumped by 846.86% to $31.0 million in 2024, then soared by 206.99% to $95.0 million in 2025.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $95.0 million in Q4 2025, $24.0 million in Q3 2025, and $129.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn - -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.74 Bn 62.74 Bn - -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn -25.54 Mn
10 Alumis 2.37 Bn 2.06 Bn - 95.01 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 95.01 Mn
Dec 31, 2025 95.01 Mn
Sep 30, 2025 24.04 Mn
Sep 30, 2025 24.04 Mn
Jun 30, 2025 129.40 Mn
Jun 30, 2025 129.40 Mn
Mar 31, 2025 39.43 Mn
Mar 31, 2025 39.43 Mn
Dec 31, 2024 30.95 Mn
Dec 31, 2024 30.95 Mn
Sep 30, 2024 -93.19 Mn
Sep 30, 2024 -93.19 Mn
Jun 30, 2024 -32.74 Mn
Jun 30, 2024 -32.74 Mn
Mar 31, 2024 -18.81 Mn
Mar 31, 2024 -18.81 Mn
Dec 31, 2023 -4.14 Mn
Dec 31, 2023 -4.14 Mn
Sep 30, 2023 7.58 Mn
Sep 30, 2023 7.58 Mn